148 related articles for article (PubMed ID: 34244869)
1. Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
Walbaum B; Puschel K; Medina L; Merino T; Camus M; Razmilic D; Navarro ME; Dominguez F; Cordova-Delgado M; Pinto MP; Acevedo F; Sánchez C
Breast Cancer Res Treat; 2021 Sep; 189(2):561-569. PubMed ID: 34244869
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes of screen-detected breast cancer.
Farshid G; Walters D
Breast Cancer Res Treat; 2018 Nov; 172(1):191-199. PubMed ID: 30046938
[TBL] [Abstract][Full Text] [Related]
3. Molecular comparison of interval and screen-detected breast cancers.
Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.
Burke JP; Power C; Gorey TF; Flanagan F; Kerin MJ; Kell MR
Eur J Surg Oncol; 2008 Feb; 34(2):149-53. PubMed ID: 17498912
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
7. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
8. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
[TBL] [Abstract][Full Text] [Related]
9. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
[TBL] [Abstract][Full Text] [Related]
10. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.
Lim ZL; Ho PJ; Khng AJ; Yeoh YS; Ong ATW; Tan BKT; Tan EY; Tan SM; Lim GH; Lee JA; Tan VK; Hu J; Li J; Hartman M
BMC Med; 2022 Aug; 20(1):239. PubMed ID: 35922814
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
[TBL] [Abstract][Full Text] [Related]
13. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis.
Alanko J; Tanner M; Vanninen R; Auvinen A; Isola J
Breast Cancer Res Treat; 2021 May; 187(1):267-274. PubMed ID: 33420595
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
16. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
[TBL] [Abstract][Full Text] [Related]
17. Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution.
Maiz C; Silva F; Domínguez F; Galindo H; Camus M; León A; Oddó D; Villarroel A; Razmilic D; Navarro ME; Medina L; Merino T; Vines E; Peña J; Maldonado D; Pinto MP; Acevedo F; Sánchez C
Ecancermedicalscience; 2020; 14():1005. PubMed ID: 32104207
[TBL] [Abstract][Full Text] [Related]
18. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry.
Yamada A; Kumamaru H; Shimizu C; Taira N; Nakayama K; Miyashita M; Honma N; Miyata H; Endo I; Saji S; Sawaki M
Eur J Cancer; 2021 Sep; 154():157-166. PubMed ID: 34293663
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]